Johnson & Johnson Profit Beats, Sales Slip 2.4%

NEW YORK ( TheStreet) -- Consumer goods and drug company Johnson & Johnson ( JNJ) beat analysts' first-quarter earnings estimates Tuesday reporting earnings excluding special items of $3.8 billion, or $1.37 a share.

This topped year-earlier earnings of $3.7 billion, or $1.36 a share. Analysts, s, on average, were calling for earnings of $1.35 a share.

Johnson & Johnson's net earnings were $3.9 billion, or $1.41 a share. The period included an after-tax gain related to the Synthes acquisition of $106 million and $276 million in after-tax charges from the DePuy ASR Hip recall and from litigation.

Global consumer sales were $3.6 billion, down 2.4% from last year. U.S. sales fell 2.2% and international sales declined 2.5%.

Shares of Johnson & Johnson ticked up 37 cents, or 0.58%, to $64.35 in premarket trading Tuesday.

-- Written by Alexandra Zendrian

>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to: tips@thestreet.com.

>To follow the writer on Twitter, go to Alexandra Zendrian.

More from Investing

Video: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Why Intel, Micron and Nvidia's Data Center Sales Are Booming

Why Intel, Micron and Nvidia's Data Center Sales Are Booming

Experts Break Down GDPR Risks for Investors

Experts Break Down GDPR Risks for Investors

Top U.S. Regulators May Be Sowing the Seeds of the Next Financial Crisis

Top U.S. Regulators May Be Sowing the Seeds of the Next Financial Crisis

Fiat Chrysler Recalls 4.8 Million Vehicles Over Cruise Control Issue

Fiat Chrysler Recalls 4.8 Million Vehicles Over Cruise Control Issue